MedMira Builds European Sales Infrastructure
MedMira Inc. announced that it has engaged Swiss-based Partner International to assist in strengthening its European Union (EU) distribution network in anticipation of CE Mark approval. With the CE approval process advancing according to schedule, MedMira is increasing its efforts in building a solid distribution network to realize sales immediately following CE approval for its MiraCare(TM) Rapid HIV Test (MiraCare(TM) HIV).
"We were looking for a partner that could act as an extension of our Sales & Marketing team to help us realize immediate product sales in the EU. Partner International's in-depth industry experience coupled with their strong European and global business connections make them an ideal partner in this market," said Giles Crouch, vice president of sales and marketing for MedMira.
MedMira plans to stand alone as the only rapid diagnostics manufacturer in the world to obtain all key international regulatory approvals for its rapid HIV tests; from the United States Food and Drug Administration (FDA), Health Canada, China State Food and Drug Administration (SFDA) and soon, the European Union CE Mark.
Other news from the department business & finance
